First medicine approved in EU for eosinophilic esophagitis
Dupixent® has been approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
